Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 17 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Set to Capitalize on North American Push to Secure Rare Earth Supply Chains
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid…
-
SPARC AI Inc. (SPAIF) Is Developing a Target Acquisition and Navigation System That Doesn’t Rely on GPS
SPARC AI provides GPS-free autonomous navigation and target acquisition systems for drones and other edge…
-
A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Expands Leadership, Global Presence in Intelligent Retail Solutions
A2Z Cust2Mate Solutions announced key additions to its global sales leadership team to accelerate growth…